30 June 2021
Blytheweigh is appointed by All Star Minerals and Pharma C. Thor Explorations Lists on the London Stock Exchange
During the second quarter of 2021, Blytheweigh (“Bw”) was pleased to be appointed by All Star Minerals and Pharma C. Also in the quarter Thor Explorations listed on AIM of the London Stock Exchange.
All Star Minerals (AQUIS: ASMO) is a company focused on identifying, evaluating, and investing in diamond and coloured gemstone projects. Its aim is to provide benefit to projects by injecting cashflow and delivering improved returns and increased value.
Pharma C (AQUIS: PCIL) is an early-stage investor and venture building company pursuing opportunities and acquisitions in the medicinal cannabis industry. The company identifies breakout companies in legal markets focusing on the UK, the EU and Israel, investing in the development of ancillary products and services.
At the end of the quarter, Thor Explorations (TSX-V/AIM: THX), a gold exploration and development company with assets in West Africa, listed on AIM of the London Stock Exchange. Thor Exploration is currently focused on its flagship project, the Segilola gold project in Nigeria, where it expects first gold pour in the coming month. The company’s Welcome Story can be viewed using the link https://www.londonstockexchange.com/discover/news-and-insights/london-stock-exchange-welcomes-thor-explorations-aim
Tim Blythe, Bw Partner, said:
“We are delighted to welcome All Star Minerals and Pharma C to Bw’s wide ranging portfolio. Both companies offer exciting investment opportunities in both the diamond and coloured gemstone, and medicinal cannabis sectors. We look forward to working alongside these companies and building their brand and story.
“We are thrilled to have also been involved in Thor Exploration’s London listing on AIM as it nears its significant operational milestone of first gold pour, and creating the first major gold district in Nigeria. We look forward to continuing our work together.”
Tim Blythe or Megan Ray on 020 7138 3204